Mark A. Goldsmith - 17 Dec 2021 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Issuer symbol
RVMD
Transactions as of
17 Dec 2021
Net transactions value
-$38,348
Form type
4
Filing time
21 Dec 2021, 15:30:15 UTC
Previous filing
08 Dec 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Sale $38,348 -1,571 -1.9% $24.41 82,622 17 Dec 2021 Direct F4, F5
holding RVMD Common Stock 37,032 17 Dec 2021 Trust F1
holding RVMD Common Stock 37,032 17 Dec 2021 Trust F2
holding RVMD Common Stock 266,506 17 Dec 2021 Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F2 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F3 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
F4 Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
F5 Includes 39,000 RSUs.

Remarks:

President and Chief Executive Officer